Insider · CIK 0001702283

YANG MICHAEL J.

Reports to the SEC for 4 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001702283

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,369 sh	—	—	5,369
2026-07-01	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+2,301 sh	—	—	9,451
2026-06-10	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+6,405 sh	—	—	19,798
2026-06-10	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.9K sh	—	—	10,891
2026-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,930 sh	—	—	7,940
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,930 sh	—	—	7,150
2025-07-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,079 sh	—	—	6,010
2025-07-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,079 sh	—	—	9,080
2025-07-01	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,518
2025-07-01	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+5,220 sh	—	—	13,159
2025-06-11	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+6,163 sh	—	—	13,393
2025-06-11	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.3K sh	—	—	11,279
2025-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,931 sh	—	—	1,931
2025-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,931 sh	—	—	7,939
2024-08-14	PCRXPacira BioSciences, Inc.P Purchase	Director	PPurchase	+2,000 sh	$12.90	+$25.8K	7,230
2024-07-01	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.1K sh	—	—	10,111
2024-07-01	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+4,079 sh	—	—	9,870
2024-06-12	PCRXPacira BioSciences, Inc.A Award	Director	AAward	+5,230 sh	—	—	5,230
2024-06-12	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,179
2024-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	Director	AAward	+5,791 sh	—	—	5,791
2023-12-14	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,356
2023-10-06	PCRXPacira BioSciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31K sh	—	—	30,967
2021-01-06	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,722 sh	—	—	9,179
2021-01-06	ACADACADIA PHARMACEUTICALS INCS Sale	EVP and CCO	SSale	−1,120 sh	$53.34	−$59.7K	8,059
2021-01-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,722 sh	—	—	8,167
2020-10-16	ACADACADIA PHARMACEUTICALS INCS Sale	EVP and CCO	SSale	−1,247 sh	$42.56	−$53.1K	6,457
2020-10-15	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+2,500 sh	—	—	7,704
2020-10-15	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−2,500 sh	—	—	5,000
2020-10-12	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.4K sh	$2.01	−$53.1K	0
2020-07-07	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+7,500 sh	$19.98	+$150K	12,704
2020-07-07	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+5,000 sh	$21.28	+$106K	17,704
2020-07-07	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+14.8K sh	$25.12	+$371K	32,454
2020-07-07	ACADACADIA PHARMACEUTICALS INCS Sale	EVP and CCO	SSale	−16.2K sh	$56.05	−$905K	16,304
2020-07-07	ACADACADIA PHARMACEUTICALS INCS Sale	EVP and CCO	SSale	−11.1K sh	$56.54	−$628K	5,204
2020-07-07	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CCO	MExercise/Conversion	−7,500 sh	—	—	570,000
2020-07-07	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CCO	MExercise/Conversion	−5,000 sh	—	—	25,000
2020-07-07	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CCO	MExercise/Conversion	−14.8K sh	—	—	44,292
2020-04-30	ACADACADIA PHARMACEUTICALS INCS Sale	EVP and CCO	SSale	−1,501 sh	$49.21	−$73.9K	5,204
2020-04-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+4,206 sh	—	—	6,705
2020-04-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP and CCO	MExercise/Conversion	−4,206 sh	—	—	12,621
2020-04-13	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+26.4K sh	—	—	26,400
2020-01-06	ACADACADIA PHARMACEUTICALS INC · Stock Options (Right to Buy)A Award	EVP and CCO	AAward	+39.5K sh	—	—	39,516
2020-01-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP and CCO	AAward	+10.9K sh	—	—	10,889
2019-12-12	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+22.5K sh	$19.98	+$450K	24,999
2019-12-12	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+10K sh	$21.28	+$213K	34,999
2019-12-12	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP and CCO	MExercise/Conversion	+73K sh	$35.86	+$2.62M	107,978
2019-12-12	ACADACADIA PHARMACEUTICALS INCS Sale	EVP and CCO	SSale	−100K sh	$44.49	−$4.47M	7,531
2019-12-12	ACADACADIA PHARMACEUTICALS INCS Sale	EVP and CCO	SSale	−5,032 sh	$43.73	−$220K	2,499
2019-12-12	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CCO	MExercise/Conversion	−22.5K sh	—	—	577,500
2019-12-12	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP and CCO	MExercise/Conversion	−10K sh	—	—	30,000

Recent filings

Accepted (ET)
Jul 64
YANG MICHAEL J.0000874015-26-000232
SEC(opens sec.gov)
Jun 124
YANG MICHAEL J.0001628280-26-043005
SEC(opens sec.gov)
Jan 204
YANG MICHAEL J.0000874015-26-000073
SEC(opens sec.gov)
Jul 174
YANG MICHAEL J.0000874015-25-000161
SEC(opens sec.gov)
Jul 24
YANG MICHAEL J.0000874015-25-000144
SEC(opens sec.gov)
Jun 134
YANG MICHAEL J.0001396814-25-000083
SEC(opens sec.gov)
Jan 174
YANG MICHAEL J.0000874015-25-000066
SEC(opens sec.gov)
Aug 144
YANG MICHAEL J.0001396814-24-000114
SEC(opens sec.gov)
Jul 34/A
YANG MICHAEL J.0000874015-24-000169
SEC(opens sec.gov)
Jul 34
YANG MICHAEL J.0000874015-24-000167
SEC(opens sec.gov)
Jun 134
YANG MICHAEL J.0001396814-24-000080
SEC(opens sec.gov)
Jan 174
YANG MICHAEL J.0000874015-24-000057
SEC(opens sec.gov)

Companies

Address

2855 GAZELLE COURT

CARLSBAD, CA, 92010